Smoking Cessation Project

Tobacco use is strongly linked to the development and progression of cancer and continues to contribute to substantial health and economic burden when smoking persists after diagnosis. Ongoing smoking among individuals with cancer is associated with poorer treatment response, increased complications, reduced quality of life, and lower survival, placing added strain on patients, families, and the healthcare system. Although smoking cessation programs have shown promise in improving clinical outcomes, the economic value of these interventions remains insufficiently understood when dealing with primary data. This study will evaluate the cost-effectiveness of a smoking cessation program using secondary data from the Shirley and Jim Fielding Northeast Cancer Centre, with the aim of assessing its impact on treatment outcomes, healthcare costs, and the long-term sustainability of cancer care delivery.